Plasma [bdsu]
Endothelin [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Diabetes Mellitus, Type 2 [dsyn]
Metabolic syndrome [dsyn]
Comparison [acty]
Oral [spco]
Combined [qlco]
Transdermal [ftcn]
Estrogen Replacement Therapy [topp]
Type 2 Diabetes [dsyn]
Metabolic syndrome [dsyn]
cardiovascular risk factor [dsyn]
postmenopausal [tmco]
Women [popg]
Endothelin-1 [aapp, bacs]
condition [dsyn]
Known [qlco]
Study [mnob]
Levels [qlco]
Endothelin-1 [aapp, bacs]
postmenopausal [tmco]
therapy, hormonal [topp]
Endothelin-1 [aapp, bacs]
Levels [qlco]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
Compared [acty]
Plasma [bdsu]
Endothelin-1 [aapp, bacs]
postmenopausal [tmco]
Type 2 [clas]
diabetic [fndg]
Women [popg]
postmenopausal [tmco]
Women [popg]
Metabolic syndrome [dsyn]
Plasma [bdsu]
Healthy Control [qlco]
postmenopausal [tmco]
Women [popg]
Basal [spco]
Values [qlco]
Endothelin-1 [aapp, bacs]
Measured [qlco]
Group [idcn]
Women [popg]
Then [tmco]
Receive [qlco]
Double [ftcn]
Trial, Crossover [resa]
Oral [spco]
Continuous [idcn]
Estradiol [horm, phsu, strd]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
Continuous [idcn]
transdermal estrogen [horm, phsu, strd]
mg day [qnco]
3 Months [tmco]
Active [ftcn]
therapy [ftcn]
Wash [acty]
Out [spco]
Endothelin-1 [aapp, bacs]
Values [qlco]
Measured [qlco]
End [spco]
treatment [ftcn]
Type 2 [clas]
diabetic [fndg]
Women [popg]
P NOS [aapp, imft]
Elevated [qlco]
Endothelin-1 [aapp, bacs]
Levels [qlco]
pg/mL [qnco]
Metabolic syndrome [dsyn]
pg/mL [qnco]
NS-1 [orch, phsu]
Elevated [qlco]
Endothelin [aapp, bacs]
Levels [qlco]
Compared [acty]
pg/mL [qnco]
Oral [spco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Failed [ftcn]
Affect [menp]
Plasma [bdsu]
Endothelin-1 [aapp, bacs]
hypertensive [fndg]
Women [popg]
Diabetes [dsyn]
Metabolic syndrome [dsyn]
Group [idcn]
Angiotensin [aapp, bacs, phsu]
Enzyme Inhibitors [phsu]
Women [popg]
Endothelin-1 [aapp, bacs]
Levels [qlco]
Oral [spco]
Hormone replacement therapy [topp]
pg/mL [qnco]
Fall [fndg]
pg/mL [qnco]
P NOS [aapp, imft]
Conclusions [idcn]
Type 2 Diabetes [dsyn]
postmenopausal [tmco]
Women [popg]
Elevated [qlco]
Endothelin-1 [aapp, bacs]
Levels [qlco]
Estrogen Replacement Therapy [topp]
Affect [menp]
Levels [qlco]
Endothelin-1 [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Type 2 Diabetes [dsyn]
Metabolic syndrome [dsyn]
